FIELD: organic chemical, pharmaceuticals.
SUBSTANCE: invention relates to new compounds having JAK3 kinase inhibitor activity, methods for production thereof, intermediates, and pharmaceutical composition containing the same. In particular disclosed are aromatic 6,7-disubstituted 3-quinolinecarboxamide derivatives of formula I and pharmaceutically acceptable salts thereof useful in production of drugs for treatment of diseases mediated with JAK3. In formula n = 0 or 1; X represents NR3 or O; Ar is selected from phenyl, tetrahydronaphthenyl, indolyl, pyrasolyl, dihydroindenyl, 1-oxo-2,3-dihydroindenyl or indasolyl, wherein each residue may be substituted with one or more groups selected from halogen, hydroxy, cyano, C1-C8-alkoxy, CO2R8, CONR9R10 C1-C8-alkyl-O-C1-C8-alkyl, etc., wherein R-groups are independently hydrogen atom or C1-C8-alkyl; meanings of other substitutes are as define in description.
EFFECT: new compounds having value biological properties.
17 cl, 222 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS | 2011 |
|
RU2573834C2 |
6-SULFAMOYLQUINOLINE-4-CARBOXYLIC ACIDS, THEIR DERIVATIVES AND COMBINATORY LIBRARY | 2003 |
|
RU2229475C1 |
ACYL THIOUREA DERIVATIVE OR SALT THEREOF AND USE THEREOF | 2009 |
|
RU2503664C2 |
QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR | 1997 |
|
RU2196137C2 |
3-CARBOXY-4-AMINOQUINOLINE DERIVATES, USEFUL AS SWEET TASTE MODIFIERS | 2011 |
|
RU2605549C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
CHROMONE DERIVATIVES, METHOD FOR PREPARING THEM AND THERAPEUTIC USES THEREOF | 2010 |
|
RU2545214C2 |
METHOD FOR PREPARING DERIVATIVES OF PHENYLACETIC ACID | 2000 |
|
RU2273628C2 |
DERIVATIVES OF TETRAHYDROQUINOLINE SHOWING PROTECTIVE ACTION FROM HIV-INFECTION | 2005 |
|
RU2350604C2 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
Authors
Dates
2006-08-20—Published
2002-05-06—Filed